BUPRENORPHINE AND NALOXONE

Course overview

BUPRENORPHINE-NALOXONE IS A COMBINATION MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF OPIOID USE DISORDER, DEFINED BY A STRONG MOTIVATION TO OBTAIN AND USE OPIOIDS IN THE FACE OF SIGNIFICANT DETRIMENTAL EFFECTS. THIS ACTIVITY DELVES INTO THE INTRICATE INTERPLAY BETWEEN BUPRENORPHINE'S ROLE AS A LONG-ACTING PARTIAL OPIOID RECEPTOR AGONIST AND NALOXONE'S FUNCTION AS AN OPIOID RECEPTOR ANTAGONIST. PARTICIPATING CLINICIANS GAIN COMPREHENSIVE INSIGHTS INTO THE INDICATIONS, MECHANISMS OF ACTION, AND CONTRAINDICATIONS OF BUPRENORPHINE-NALOXONE, WITH A FOCUS ON THE EFFICACY OF ADDRESSING BOTH ILLICIT AND PRESCRIPTION OPIOID ABUSE.TOPICS ENCOMPASS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, OFF-LABEL USES, DOSING STRATEGIES, PHARMACOKINETICS, MONITORING, AND RELEVANT DRUG INTERACTIONS. BY EQUIPPING HEALTHCARE PROFESSIONALS WITH THIS EXTENSIVE KNOWLEDGE, THIS ACTIVITY AIMS TO EMPOWER THEM TO MAKE INFORMED DECISIONS AND APPLY BUPRENORPHINE-NALOXONE EFFECTIVELY IN OPIOID USE DISORDER MANAGEMENT.